Investing Profile

John Gustofson

InvestorVC
President, Head of Ventures at Chugai Venture Fund (CVF)
abbvie.comMassachusetts
Photo of John Gustofson, President at Chugai Venture Fund (CVF)

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Miami University Network
51 CONNECTIONS
AstraZeneca Network
28 CONNECTIONS
AbbVie Network
20 CONNECTIONS
AbbVie Network
20 CONNECTIONS
AbbVie Network
20 CONNECTIONS
cb
$100K - $1.5M
$1.5M
7
CompanyStageDateRound SizeTotal Raised
Ten63 Therapeutics
Series UnknownFeb 2026
$16M
Co-investors: Po Bronson (SOSV), Arvind Gupta (Mayfield Fund), Damien Petty (Morpheus Ventures), Clay Thorp (Hatteras Venture Partners), Mike Dial (Hatteras Venture Partners)
Leal Therapeutics
Series AAug 2025$30M
Series UnknownOct 2024$6M
$36M
Stylus Medicine
Series AMay 2025$85M
$85M
Caraway Therapeutics
Series ANov 2018$23M
$46M
Co-investors: Reza Halse (RA Capital Management), Jack Kenney (Estuary Capital Management, LP)
Ribometrix
Series ANov 2018$30M
SeedOct 2017$8M
$38M
Co-investors: Mike Dial (Hatteras Venture Partners), Hakan Goker (MDC Ventures (formerly KBS Ventures))
Scientist Ribozyme PharmaceuticalsPresent
Business and Product Development Manager Ribozyme PharmaceuticalsPresent
Consultant George Mason University - Antonin Scalia Law SchoolPresent
Principal Consultant PA ConsultingPresent
Director, Business and Market Development Therion BiologicsPresent
Director, Business Development Altus PharmaceuticalsPresent
Business Development Director AstraZenecaPresent
Sr. Director, Ventures & Early Stage Collaborations AbbViePresent
Sr. Director, Ventures & Early Stage Collaborations AbbViePresent
Managing Director, AbbVie Ventures AbbViePresent
President, Head of Ventures Ribozyme PharmaceuticalsPresent
President, Head of Ventures Chugai Venture Fund (CVF)Present
Western Illinois University BS Microbiology
Miami University MS Molecular Biology
Sign in with Google →
Sign in with Google →